Literature DB >> 277211

The nitroimidazoles as radiosensitizers and cytotoxic agents.

E J Hall, R Miller, M Astro, F Rini.   

Abstract

Using hamster cells in culture, the radiosensitizing and cytotoxic properties of 8 electron-affinic drugs have been compared. These include nitrofurans derivatives as well as 2 and 5-nitroimidazoles. Most work has been performed with misonidazole for which it appears that, at 37 degree C, the concentration of drug required to produce a given level of cell killing is inversely proportional to the square of the exposure time. Misonidazole was also compared with X-rays for its ability to produce neoplastic transformations in vitro, using the C3H 10T 1/2 cell line.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 277211      PMCID: PMC2149404     

Source DB:  PubMed          Journal:  Br J Cancer Suppl        ISSN: 0306-9443


  7 in total

1.  Hypoxic sensitizers: radiobiological studies at the cellular level.

Authors:  E J Hall; L Roizin-Towle
Journal:  Radiology       Date:  1975-11       Impact factor: 11.105

2.  Selective chemotherapy of noncycling cells in an in vitro tumor model.

Authors:  R M Sutherland
Journal:  Cancer Res       Date:  1974-12       Impact factor: 12.701

3.  Quantitative and qualitative studies of chemical transformation of cloned C3H mouse embryo cells sensitive to postconfluence inhibition of cell division.

Authors:  C A Reznikoff; J S Bertram; D W Brankow; C Heidelberger
Journal:  Cancer Res       Date:  1973-12       Impact factor: 12.701

4.  Split-dose experiments with hypoxic cells. Implications for fractionated and low-dose-rate radiotherapy.

Authors:  E J Hall; S Lehnert; L Roizin-Towle
Journal:  Radiology       Date:  1974-08       Impact factor: 11.105

5.  Increased cell killing by metronidazole and nitrofurazone of hypoxic compared to aerobic mammalian cells.

Authors:  J K Mohindra; A M Rauth
Journal:  Cancer Res       Date:  1976-03       Impact factor: 12.701

6.  X-radiation-induced transformation in a C3H mouse embryo-derived cell line.

Authors:  M Terzaghi; J B Little
Journal:  Cancer Res       Date:  1976-04       Impact factor: 12.701

7.  Cytotoxicity of Ro-07-0582; enhancement by hyperthermia and protection by cysteamine.

Authors:  E J Hall; M Astor; C Geard; J Biaglow
Journal:  Br J Cancer       Date:  1977-06       Impact factor: 7.640

  7 in total
  5 in total

1.  A Multimodal Molecular Imaging Study Evaluates Pharmacological Alteration of the Tumor Microenvironment to Improve Radiation Response.

Authors:  Yoichi Takakusagi; Sarwat Naz; Kaori Takakusagi; Masahiro Ishima; Hiroshi Murata; Keisuke Ohta; Masahiko Miura; Fumio Sugawara; Kengo Sakaguchi; Shun Kishimoto; Jeeva P Munasinghe; James B Mitchell; Murali C Krishna
Journal:  Cancer Res       Date:  2018-10-09       Impact factor: 12.701

2.  Factors influencing the chemosensitization of melphalan by misonidazole.

Authors:  V S Randhawa; F A Stewart; J Denekamp; M R Stratford
Journal:  Br J Cancer       Date:  1985-02       Impact factor: 7.640

3.  Is tumour radiosensitization by misonidazole a general phenomenon?

Authors:  J Denekamp; D G Hirst; F A Stewart; N H Terry
Journal:  Br J Cancer       Date:  1980-01       Impact factor: 7.640

4.  Cytotoxicity of metronidazole (Flagyl) and misonidazole (Ro-07-0582): enhancement by lactate.

Authors:  J S Mahood; R L Willson
Journal:  Br J Cancer       Date:  1981-03       Impact factor: 7.640

5.  In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: methotrexate, 5-fluorouracil and adriamycin.

Authors:  I F Tannock
Journal:  Br J Cancer       Date:  1980-12       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.